BioWorld

July 19, 2000

View Archived Issues

Insmed, Taisho Pharmaceutical In $32M Deal To Develop INS-1

Read More

UroGenesys, Genentech Align In $33M Prostate Cancer Deal

Read More

Other News To Note

Read More

DeCode, Transgenomic IPOs Raise $240M In Revived Market

Read More

Avax Buying French Firm In Stock Deal Valued Up To $29M

Read More

New Lentivirus Vector Transfers Thalassemia Genes To Blood- Forming Stem Cells In Mouse Model

Read More

New Company Raises $40M To Build Proteomics Infrastructure

Read More